pteridines has been researched along with Adenocarcinoma of Lung in 1 studies
Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdulrahman, N | 1 |
| Siveen, KS | 1 |
| Joseph, JM | 1 |
| Osman, A | 1 |
| Yalcin, HC | 1 |
| Hasan, A | 1 |
| Uddin, S | 1 |
| Mraiche, F | 1 |
1 other study available for pteridines and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Inhibition of p90 ribosomal S6 kinase potentiates cisplatin activity in A549 human lung adenocarcinoma cells.
Topics: A549 Cells; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autop | 2020 |